Ongoing valsartan shortages due to recalls prompt FDA prioritization.
FDA Updates
Advertisement
Indicated for breast cancer, and gastric or gastroesophageal junction adenocarcinoma.
Advertisement
Eli Lilly creates generic Humalog priced 50% lower
Restricted implants indicated for maintenance of opioid dependency.
Sublingual form approved for short-term use.
The new device will increase real-time personalization and predictive diagnostics for patients.
Advertisement
Anthelmintic tablet for patients 6 years of age and older.
What you need to know about the von Willebrand factor (vWF)-directed antibody fragment.
What you need to know about the new botulinum toxin product.
Advertisement
Approved and upcoming drugs to look forward to this year.
Approved by the FDA in September, this new drug serves as a first-line therapy for patients with particular metastatic non-small lung cancer.
Advertisement
Advertisement
Trending on Drug Topics
1
American Pharmacists Month: PBM Reform, Provider Status Key in Stopping Pharmacy Deserts
2
Pfizer Reports Strong Phase 2 Data for 25-Valent Pediatric PCV
3
PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule
4
HHS Lets Pharmacies Compound Peptides as FDA Writes Official Rule
5